‘Unit’ Tagged Posts

Unit three – Dermatology

...

 

Unit three Dermatology Pt 2 and Ophtho Pt 1

 

Goodfellow Unit Webinar: Frequent infections

 

Aurobindo Pharma receives USFDA approval for its 6th Unit: Aurobindo Pharma New Drugs

 

From 1 January 2005, Organon and integrated Diosynth the pharmaceutical giant Akzo Nobel, a business unit

 

Dublin (NYSE) 24 October 2005

Headquarters in the Netherlands, Akzo Nobel is active in three areas: pharmaceuticals, paints and chemicals. The Division consists of three pharmaceutical company, Organon, Intervet and Diosynth which manufacture products for human and animal health. From 1 January 2005, Organon and Diosynth integrated into a business unit. Products by the pharmaceutical company is also developing oral contraceptives, antidepressants, infertility treatments and veterinary vaccines

Research and Markets (http://www.researchandmarkets.com/reports/c26023) has the addition of Akzo Nobel Pharmaceutical Company Intelligence Report announced its offer

Pharmaceutical Company Intelligence Reports provide a full review of the activities of the company, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are based on products, international activities and R & D, and included a full, detailed financial analysis of five years. An introduction to each report and a complete table of contents is provided for the review. More than 40 companies Intelligence Reports are currently available.

the contents:

main operational results

FINANCIAL INDICATORS

RECENT HISTORY / CORPORATE STRATEGY

AGREEMENTS

structure and activities

GEOGRAPHICAL BREAKDOWN

PRODUCT PORTFOLIO

PHARMACEUTICAL subsidiaries and affiliates

LIST OF TABLES

INDEX OF CHARTS

these companies:

Vernalis Plc

Neopharm

Barr Pharmaceuticals, Inc.

Pharmacopeia Inc

BioFocus Plc

Agenix Ltd

Genaissance Pharmaceuticals Inc

Laboratoire Theramex

Cypress Bioscience Inc.

Kiadis BV

Valenti Inc

Lexicon Genetics Incorporated

Fabre-Kramer Pharmaceuticals Inc

GeneGo Inc

Entelos Inc

Pharming Group NV

BioDiem Ltd

Hemosol Corporation

Prasco Laboratories LLC

Meiji Seika Kaisha Ltd.

Gene Logic Inc

Grupo Uriach

Human Genome Sciences Inc. (HGS)

STADA Arzneimittel AG

sanofi-aventis

Sosei Co Ltd

Maastricht University

Pfizer

Ligand Pharmaceuticals

Xenogen Corp.

Schering AG

Compugen Ltd.

BioMarin Pharmaceutical Inc.

Affymetrix Inc.

doubleTwist Inc

De Novo Pharmaceuticals Ltd.

Cortex Pharmaceuticals Inc

Biobase GmbH

Corixa Corporation

Santen Pharmaceutical

CIMA Labs Inc

Incyte Genomics Inc.

Ardent Pharmaceuticals Inc

Savient Pharmaceuticals Inc

Pherin Pharmaceuticals Inc

Roche

Orgalutran Agreement

serotonin receptor ligands Agreement

Serono

Johnson & Johnson

For more information visit http://www.researchandmarkets.com/reports/c26023

Laura Wood

Senior Manager

Research and Markets

Fax: +353 1 4100 980

###

clear = “all”